Emergence and clinical insights into the pathology of Chikungunya virus infection

Expert Review of Anti-Infective Therapy

Volumn 8, Issue 9, 2010, Pages 987-996

  Jaffar Bandjee, Marie Christine ^a   Ramful, Duksha ^a   Gauzere, Bernard Alex ^a   Hoarau, Jean Jacques ^a   Krejbich Trotot, Pascale ^a   Robin, Stephanie ^a   Ribera, Anne ^a   Selambarom, Jimmy ^a   Gasque, Philippe ^a  

^a UNIVERSITÉ DE LA RÉUNION   (France)

Author keywords

anti TNF ; arthritis; Chikungunya; chloroquine; encephalitis; immunology; methotrexate; mosquito; neutralizing antiserum; vaccine

Indexed keywords

ADALIMUMAB; ALPHA INTERFERON; CHIKUNGUNYA FEVER VACCINE; CHLOROQUINE; DIETHYLTOLUAMIDE; ETANERCEPT; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INSECT REPELLENT; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; QUININE; RIBAVIRIN; SALAZOSULFAPYRIDINE; UNCLASSIFIED DRUG; VIRUS RNA; VIRUS VACCINE;

ADAPTIVE IMMUNITY; AEDES; AEDES AEGYPTI; AEDES ALBOPICTUS; ALPHA VIRUS; ARTHRALGIA; CHIKUNGUNYA; CHIKUNGUNYA ALPHAVIRUS; CHRONIC ARTHRITIS; CLINICAL TRIAL; ENCEPHALITIS; EPIDEMIC; EPIDEMIOLOGICAL DATA; FEVER; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNE RESPONSE; INFECTION CONTROL; INFECTION PREVENTION; INSECT CONTROL; MORTALITY; NONHUMAN; PASSIVE IMMUNIZATION; PATHOPHYSIOLOGY; PATIENT CARE; RASH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SYMPTOM; VERTICAL TRANSMISSION; VIROLOGY; VIRUS DETECTION; VIRUS TRANSMISSION;

AEDES; ALPHAVIRUS INFECTIONS; ANIMALS; CHIKUNGUNYA VIRUS; COMMUNICABLE DISEASES, EMERGING; ENCEPHALITIS; FEMALE; HUMANS; INSECT REPELLENTS; INSECT VECTORS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VACCINATION; VIRAL VACCINES; WORLD HEALTH;

EID: 77956471505     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.10.92     Document Type: Review

References (99)

1. Pialoux G, Gauzere BA, Jaureguiberry S, Strobel M. Chikungunya, an epidemic arbovirosis. Lancet Infect. Dis. 7, 319-327 (2007).
2. Jaffar-Bandjee MC, Das T, Hoarau JJ et al. Chikungunya virus takes centre stage in virally induced arthritis: possible cellular and molecular mechanisms to pathogenesis. Microbes Infect. 11, 1206-1218 (2009).
3. Strauss JH, Strauss EG. The alphaviruses: gene expression, replication, and evolution. Microbiol. Rev. 58, 491-562 (1994).
4. Robinson MC. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-1953. I. Clinical features. Trans. R. Soc. Trop. Med. Hyg. 49, 28-32 (1955).
5. Lemant J, Boisson V, Winer A et al. Serious acute Chikungunya virus infection requiring intensive care during the Reunion Island outbreak in 2005-2006. Crit. Care Med. 36, 2536-2541 (2008).
6. Mavalankar D, Shastri P, Raman P. Chikungunya epidemic in India: a major public-health disaster. Lancet Infect. Dis. 7, 306-307 (2007).
7. Sissoko D, Malvy D, Ezzedine K et al. Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl. Trop. Dis. 3, e389 (2009).
8. Ross RW. The Newala epidemic. III. The virus: isolation, pathogenic properties and relationship to the epidemic. J. Hyg. 54, 177-191 (1956).
9. Filipe AF, Pinto MR. Arbovirus studies in Luanda, Angola. 2. Virological and serological studies during an outbreak of dengue-like disease caused by the Chikungunya virus. Bull. World Health Organ. 49, 37-40 (1973).
10. Ivanov AP, Ivanova OE, Lomonosov NN et al. Serological investigations of Chikungunya virus in the Republic of Guinea. Ann. Soc. Belg. Med. Trop. 72, 73-74 (1992).
11. Moore DL, Reddy S, Akinkugbe FM et al An epidemic of Chikungunya fever at Ibadan, Nigeria, 1969. Ann. Trop. Med. Parasitol. 68, 59-68 (1974).
12. Guilherme JM, Gonella-Legall C, Legall F, Nakoume E, Vincent J. Seroprevalence of fve arboviruses in Zebu cattle in the Central African Republic. Trans. R. Soc. Trop. Med. Hyg. 90, 31-33 (1996).
13. McIntosh BM, Harwin RM, Paterson HE, Westwater ML. An epidemic of Chikungunya in south-eastern southern Rhodesia. Cent. Afr. J. Med. 43, 351-359 (1963).
14. Mackenzie JS, Chua KB, Daniels PW et al. Emerging viral diseases of Southeast Asia and the Western Pacifc. Emerg Infect. Dis. 7, 497-504 (2001).
15. Porter KR, Tan R, Istary Y et al. A serological study of Chikungunya virus transmission in Yogyakarta, Indonesia: evidence for the frst outbreak since 1982. Southeast Asian J. Trop. Med. Public Health 35, 408-415 (2004).
16. Rao TR. Immunological surveys of arbovirus infections in South-East Asia, with special reference to dengue, Chikungunya, and Kyasanur Forest disease. Bull. World Health Organ. 44, 585-591 (1971).
17. Sergon K, Njuguna C, Kalani R et al. Seroprevalence of Chikungunya virus (CHIKV) infection on Lamu Island, Kenya, October 2004. Am. J. Trop. Med. Hyg. 78, 333-337 (2008).
18. Sergon K, Yahaya AA, Brown J et al. Seroprevalence of Chikungunya virus infection on Grande Comore Island, union of the Comoros, 2005. Am. J. Trop. Med. Hyg. 76, 1189-1193 (2007).
19. Gerardin P, Barau G, Michault A et al Multidisciplinary prospective study of mother-to-child Chikungunya virus infections on the island of La Reunion. PLoS Med 5, e60 (2008).
20. Renault P, Solet JL, Sissoko D et al A major epidemic of Chikungunya virus infection on Reunion Island, France, 2005-2006. Am. J. Trop. Med. Hyg. 77, 727-731 (2007).
21. Zheng K, Li J, Zhang Q et al. Genetic analysis of Chikungunya viruses imported to mainland China in 2008. Virol. J. 7, 8 (2010).
22. Rezza G, Nicoletti L, Angelini R et al Infection with Chikungunya virus in Italy: an outbreak in a temperate region. Lancet 370, 1840-1846 (2007).
23. Powers AM, Brault AC, Tesh RB, Weaver SC. Re-emergence of Chikungunya and O'nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships. J. Gen. Virol. 81, 471-479 (2000).
24. Powers AM, Logue CH. Changing patterns of Chikungunya virus: re-emergence of a zoonotic arbovirus. J. Gen. Virol. 88, 2363-2377 (2007).
25. Kariuki Njenga M, Nderitu L, Ledermann JP et al. Tracking epidemic Chikungunya virus into the Indian Ocean from East Africa. J. Gen. Virol. 89, 2754-2760 (2008).
26. Huang JH, Yang CF, Su CL et al Imported Chikungunya virus strains, Taiwan, 2006-2009. Emerg. Infect. Dis. 15, 1854-1856 (2009).
27. Parola P, de Lamballerie X, Jourdan J et al Novel Chikungunya virus variant in travelers returning from Indian Ocean islands. Emerg. Infect. Dis. 12, 1493-1499 (2006).
28. Moore CG, Mitchell CJ. Aedes albopictus in the United States: ten-year presence and public health implications. Emerg. Infect. Dis. 3, 329-334 (1997).
29. Gould EA, Higgs S. Impact of climate change and other factors on emerging arbovirus diseases. Trans. R. Soc. Trop. Med. Hyg. 103, 109-121 (2009).
30. Schuffenecker I, Iteman I, Michault A et al. Genome microevolution of Chikungunya viruses causing the Indian Ocean outbreak. PLoS Med. 3, e263 (2006).
31. Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. A single mutation in Chikungunya virus affects vector specifcity and epidemic potential. PLoS Pathog. 3, e201 (2007).
32. Vazeille M, Moutailler S, Coudrier D et al. Two Chikungunya isolates from the outbreak of La Reunion (Indian Ocean) exhibit different patterns of infection in the mosquito, Aedes albopictus. PLoS One 2, e1168 (2007).
33. Kam YW, Ong EK, Renia L, Tong JC, Ng LF. Immuno-biology of Chikungunya and implications for disease intervention. Microbes Infect. 11, 1186-1196 (2009).
34. Kumar NP, Joseph R, Kamaraj T, Jambulingam P. A226V mutation in virus during the 2007 Chikungunya outbreak in Kerala, India. J. Gen. Virol. 89, 1945-1948 (2008).
35. Leo YS, Chow AL, Tan LK et al. Chikungunya outbreak, Singapore, 2008. Emerg. Infect. Dis. 15, 836-837 (2009).
36. Robillard PY, Boumahni B, Gerardin P et al. [Vertical maternal fetal transmission of the Chikungunya virus. Ten cases among 84 pregnant women]. Presse Med. 35, 785-788 (2006).
37. Ramful D, Carbonnier M, Pasquet M et al. Mother-to-child transmission of Chikungunya virus infection. Pediatr. Infect. Dis. J. 26, 811-815 (2007).
38. Rao G, Khan YZ, Chitnis DS. Chikungunya infection in neonates. Ind. Pediatr. 45, 240-242 (2008).
39. Senanayake MP, Senanayake SM, Vidanage KK, Gunasena S, Lamabadusuriya SP. Vertical transmission in Chikungunya infection. Ceylon Med. J. 54, 47-50 (2009).
40. Samperiz E, Gerardin P, Noormahomed T, Beullier G, Boya I. [Perinatal transmission of Chikungunya virus infection: 47 cases from La Réunion Island]. Bull. Soc. Pathol. Exot. Filiales 100, 355 (2007).
41. Ramful D, Fourmaintraux A, Rollot A et al. [Neurodevelopmental outcome at 2 years in children with materno-fetal Chikungunya virus infection]. Arch. Pediatr. Livre des Résumés 17(6, Suppl. 1), 17 (2010).
42. Fritel X, Rollot O, Gerardin P et al. Chikungunya virus infection during pregnancy, Reunion, France, 2006. Emerg. Infect. Dis. 16, 418-425 (2010).
43. Touret Y, Randrianaivo H, Michault A et al. [Early maternal-fetal transmission of the Chikungunya virus]. Presse Med. 35, 1656-1658 (2006).
44. Couderc T, Chretien F, Schilte C et al. A mouse model for Chikungunya: young age and ineffcient type-I interferon signaling are risk factors for severe disease. PLoS Pathog. 4, e29 (2008).
45. Grivard P, Le Roux K, Laurent P et al Molecular and serological diagnosis of Chikungunya virus infection. Pathol. Biol. (Paris) 55, 490-494 (2007).
46. Ernould S, Walters H, Alessandri JL et al. [Chikungunya in paediatrics: epidemic of 2005-2006 in Saint-Denis, Reunion Island]. Arch. Pediatr. 15, 253-262 (2008).
47. Le Bomin A, Hebert JC, Marty P, Delaunay P. [Confrmed Chikungunya in children in Mayotte. Description of 50 patients hospitalized from February to June 2006]. Med. Trop. (Mars.) 68, 491-495 (2008).
48. Valamparampil JJ, Chirakkarot S, Letha S, Jayakumar C, Gopinathan KM. Clinical profle of Chikungunya in infants. Ind. J. Pediatr. 76, 151-155 (2009).
49. Robin S, Ramful D, Le Seach F et al Neurologic manifestations of pediatric Chikungunya infection. J. Child Neurol. 23, 1028-1035 (2008).
50. Lewthwaite P, Vasanthapuram R, Osborne JC et al. Chikungunya virus and central nervous system infections in children, India. Emerg. Infect. Dis. 15, 329-331 (2009).
51. Couderc T, Khandoudi N, Grandadam M et al. Prophylaxis and therapy for Chikungunya virus infection. J. Infect. Dis. 200, 516-523 (2009).
52. Borgherini G, Poubeau P, Staikowsky F et al. Outbreak of Chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. Clin. Infect. Dis. 44, 1401-1407 (2007).
53. Lakshmi V, Neeraja M, Subbalaxmi MV et al. Clinical features and molecular diagnosis of Chikungunya fever from South India. Clin. Infect. Dis. 46, 1436-1442 (2008).
54. Her Z, Kam YW, Lin RT, Ng LF. Chikungunya: a bending reality. Microbes Infect. 11, 1165-1176 (2009).
55. Osterrieth P, Deleplanque-Liegeois P, Renoirte R. [Research on the Chikungunya virus in the Belgian Congo. II. Serological investigation]. Ann. Soc. Belg. Med. Trop. 1920) 40 205-213 (1960).
56. Panning M, Grywna K, van Esbroeck M, Emmerich P, Drosten C. Chikungunya fever in travelers returning to Europe from the Indian Ocean region, 2006. Emerg. Infect. Dis. 14, 416-422 (2008).
57. Hoarau JJ, Bandjee MC, Trotot PK et al Persistent chronic infammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J. Immunol. 184, 5914-5927 (2010).
58. Ng LF, Chow A, Sun YJ et al. IL-1p, IL-6, and RANTES as biomarkers of Chikungunya severity. PLoS One 4, e4261 (2009).
59. Economopoulou A, Dominguez M, Helynck B et al. Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Reunion. Epidemiol. Infect. 137, 534-541 (2009).
60. Mazaud R, Salaun JJ, Montabone H, Goube P, Bazillio R. [Acute neurologic and sensorial disorders in dengue and Chikungunya fever]. Bull. Soc. Pathol Exot. Filiales 64, 22-30 (1971).
61. Lebrun G, Chadda K, Reboux AH, Martinet O, Gauzere BA. Guillain-Barre syndrome after Chikungunya infection. Emerg. Infect. Dis. 15, 495-496 (2009).
62. Wang E, Volkova E, Adams AP et al Chimeric alphavirus vaccine candidates for Chikungunya. Vaccine 26, 5030-5039 (2008).
63. Ziegler SA, Lu L, da Rosa AP, Xiao SY, Tesh RB. An animal model for studying the pathogenesis of Chikungunya virus infection. Am. J. Trop. Med. Hyg 79, 133-139 (2008).
64. Mahesh G, Giridhar A, Shedbele A, Kumar R, Saikumar SJ. A case of bilateral presumed Chikungunya neuroretinitis. Ind. J. Ophthalmol. 57, 148-150 (2009).
65. Prashant S, Kumar AS, Basheeruddin DD, Chowdhary TN, Madhu B. Cutaneous manifestations in patients suspected of Chikungunya disease. Ind. J. Dermatol. 54, 128-131 (2009).
66. Talarmin F, Staikowsky F, Schoenlaub P et al. [Skin and mucosal manifestations of Chikungunya virus infection in adults in Reunion Island]. Med. Trop. (Mars.) 67, 167-173 (2007).
67. Tandale BV, Sathe PS, Arankalle VA et al. Systemic involvements and fatalities during Chikungunya epidemic in India, 2006. J. Clin. Virol. 46(2), 145-149 (2009).
68. Sankari T, Hoti SL, Govindaraj V, Das PK. Chikungunya and respiratory viral infections. Lancet Infect. Dis. 8, 3-4 (2008).
69. De Andrade DC, Jean S, Clavelou P, Dallel R, Bouhassira D. Chronic pain associated with the Chikungunya fever: long lasting burden of an acute illness. BMC Infect. Dis. 10, 31 (2010).
70. Soumahoro MK, Gerardin P, Boelle PY et al. Impact of Chikungunya virus infection on health status and quality of life: a retrospective cohort study. PLoS One 4, e7800 (2009).
71. Tesh RB. Arthritides caused by mosquito-borne viruses. Annu. Rev. Med. 33, 31-40 (1982).
72. Harley D, Sleigh A, Ritchie S. Ross River virus transmission, infection, and disease: a cross-disciplinary review. Clin. Microbiol. Rev. 14, 909-932 (2001).
73. Levine B, Hardwick JM, Griffn DE. Persistence of alphaviruses in vertebrate hosts. Trends Microbiol. 2, 25-28 (1994).
74. Suhrbier A, La Linn M. Clinical and pathologic aspects of arthritis due to Ross River virus and other alphaviruses. Curr. Opin. Rheumatol. 16, 374-379 (2004).
75. Toivanen A. Alphaviruses: an emerging cause of arthritis? Curr. Opin. Rheumatol. 20, 486-490 (2008).
76. Brighton SW, Simson I W. A destructive arthropathy following Chikungunya virus arthritis-a possible association. Clin. Rheumatol. 3, 253-258 (1984).
77. Fourie ED, Morrison JG. Rheumatoid arthritic syndrome after Chikungunya fever. S. Afr. Med. J. 56, 130-132 (1979).
78. Simon F, Parola P, Grandadam M et al. Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases. Medicine 86, 123-137 (2007).
79. Borgherini G, Poubeau P, Jossaume A et al. Persistent arthralgia associated with Chikungunya virus: a study of 88 adult patients on Reunion island. Clin. Infect. Dis. 47, 469-475 (2008).
80. Manimunda SP, Vijayachari P, Uppoor R et al. Clinical progression of Chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans. R. Soc. Trop. Med. Hyg. 104, 392-399 (2010).
81. Chopra A, Anuradha V, Lagoo-Joshi V et al. Chikungunya virus aches and pains: an emerging challenge. Arthritis Rheum. 58, 2921-2922 (2008).
82. Bouquillard E, Combe B. Rheumatoid arthritis after Chikungunya fever: a prospective follow-up study of 21 cases. Ann. Rheum. Dis. 68, 1505-1506 (2009).
83. Malvy D, Ezzedine K, Mamani-Matsuda M et al. Destructive arthritis in a patient with Chikungunya virus infection with persistent specifc IgM antibodies. BMC Infect. Dis. 9, 200 (2009).
84. Labadie K, Larcher T, Joubert C et al. Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J. Clin. Invest. 120, 894-906 (2010).
85. Sorge F. [Prevention with repellent in children]. Arch Pediatr. 16(Suppl. 2), S115-S122 (2009).
86. Brighton SW. Chloroquine phosphate treatment of chronic Chikungunya arthritis. An open pilot study. S. Afr. Med. J. 66, 217-218 (1984).
87. Maheshwari RK, Srikantan V, Bhartiya D. Chloroquine enhances replication of Semliki Forest virus and encephalomyocarditis virus in mice. J. Virol. 65, 992-995 (1991).
88. De Lamballerie X, Ninove L, Charrel RN. Antiviral treatment of Chikungunya virus infection. Infect. Disord. Drug Targets 9, 101-104 (2009).
89. Gardner J, Anraku I, Le TT et al. Chikungunya virus arthritis in adult wild-type mice. J. Virol. 84(16), 8021-8032 (2010).
90. Malet H, Coutard B, Jamal S et al. The crystal structures of Chikungunya and Venezuelan equine encephalitis virus nsP3 macro domains defne a conserved adenosine binding pocket. J. Virol. 83, 6534-6545 (2009).
91. Dash PK, Tiwari M, Santhosh SR, Parida M, Lakshmana Rao PV. RNA interference mediated inhibition of Chikungunya virus replication in mammalian cells. Biochem. Biophys. Res. Commun. 376, 718-722 (2008).
92. Thiboutot MM, Kannan S, Kawalekar OU et al. Chikungunya: a potentially emerging epidemic? PLoS Negl. Trop. Dis. 4, e623 (2010).
93. Eckels KH, Harrison VR, Hetrick FM. Chikungunya virus vaccine prepared by Tween-ether extraction. Appl. Microbiol. 19, 321-325 (1970).
94. Harrison VR, Eckels KH, Bartelloni PJ, Hampton C. Production and evaluation of a formalin-killed Chikungunya vaccine. J. Immunol. 107, 643-647 (1971).
95. Levitt NH, Ramsburg HH, Hasty SE et al. Development of an attenuated strain of Chikungunya virus for use in vaccine production. Vaccine 4, 157-162 (1986).
96. McClain DJ, Pittman PR, Ramsburg HH et al. Immunologic interference from sequential administration of live attenuated alphavirus vaccines. J. Infect. Dis. 177, 634-641 (1998).
97. Edelman R, Tacket CO, Wasserman SS et al. Phase II safety and immunogenicity study of live Chikungunya virus vaccine TSI-GSD-218. Am. J. Trop. Med. Hyg. 62, 681-685 (2000).
98. Muthumani K, Lankaraman KM, Laddy DJ et al. Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus. Vaccine 26, 5128-5134 (2008).
99. Akahata W, Yang ZY, Andersen H et al. A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat. Med. 16, 334-338